Trial intelligence / Profile preview

STAT: Single vs. Divided Dose Thymoglobulin in Kidney Transplant

NCT00906204Phase 2Completed

Sponsor
Wright State University
Start
Mar 2010
Primary completion
Jul 2014
Countries
1
01

Overview

A Phase 2 trial of antithymocyte globulin in end stage renal disease (ESRD), sponsored by Wright State University. Started Mar 2010; status: completed.

02

Drugs

antithymocyte globulin
03

Conditions

end stage renal disease (ESRD)

Beyond the preview

Go deeper on NCT00906204.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00906204.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call